Editas Medicine, Inc.
EDIT
•Stock Analysis$3.77
+0.00 (+0.00%)• Live
Editas Medicine, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Editas Medicine, Inc.
Key Financial Metrics
for Editas Medicine, Inc.
P/E Ratio
-0.67
Revenue Growth
-58.64%
EPS Growth
-42.57%
Market Cap
$0.17B
Dividend Yield
0.00%
Debt/Equity
0.50
ROIC
-90.41%
FCF Yield
-126.68%
View additional metrics
Valuation
P/B Ratio2.70
EV/Sales2.00
Financial Health
Current Ratio3.08
Return on Assets-95.29%
Analyst Recommendations
for Editas Medicine, Inc.
24 analysts
Consensus: Hold
About
for Editas Medicine, Inc.
Company Details
for Editas Medicine, Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Gilmore O'Neill
Employees
246
Market Cap
339.00M
Exchange
NASDAQ Global Select
IPO Date
February 3, 2016
Website
www.editasmedicine.comCIK
0001650664
ISIN
US28106W1036
CUSIP
28106W103
Country
US
Balance Sheet
for Editas Medicine, Inc.
Cash Flow Statement
for Editas Medicine, Inc.
Income Statement
for Editas Medicine, Inc.
News
No news available at the moment.